Literature DB >> 33721834

cGAS promotes sepsis in radiotherapy of cancer by up-regulating caspase-11 signaling.

Ming Wu1, Jian Shi2, Shasha He3, Di Wang4, Na Zhang5, Zhigan Wang5, Fanfan Yang6, Jun He6, Danping Hu7, Xinyu Yang8, Chuang Yuan9.   

Abstract

Radiotherapy is the most common strategy in the treatment of cancer. However, radiation-induced acute complications, in particular sepsis, render patients in a life-threatening status or lead to delay of therapy that largely influences patients' overall responses. The understanding of sepsis in radiotherapy is currently scant and effective medicine is not available by far. Here, with WT mice as control, we challenged mice deficient to cGas, Caspase-11, Gsdmd or Asc with cecal ligation and puncture (CLP, a sepsis model) after a treatment of thorax irradiation. We found that radiation robustly upgraded caspase-11 pathway in irradiated region and consequently deteriorated lung injury and mortality in the sepsis model. cGas knockout markedly attenuated radiation-upgraded caspase-11 and restored sepsis. Deficiency of non-canonical inflammasome, caspase-11 and the downstream GSDMD, rather than an AIM2 inflammasome component, ASC, dramatically protected against radiation-promoted injury and mortality in septic mice. The protection may attribute to the inhibition of caspase-11-mediated pyroptosis in endothelial cells of the lung. Thus, blocking cGAS/caspase-11 signaling would be an adjuvant treatment strategy for preventing sepsis in radiotherapy of cancer.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Caspase-11; Injury; Lung; Radiotherapy; Sepsis; cGAS

Mesh:

Substances:

Year:  2021        PMID: 33721834     DOI: 10.1016/j.bbrc.2021.03.003

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  1 in total

1.  Roles of Pyroptosis-Related Gene Signature in Prediction of Endometrial Cancer Outcomes.

Authors:  Yili Chen; Yuandong Liao; Qiqiao Du; Chunliang Shang; Shuhang Qin; Kaping Lee; Qiaojian Zou; Junxiu Liu; Shuzhong Yao
Journal:  Front Med (Lausanne)       Date:  2022-03-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.